Active Not RecruitingNCT06707753
Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD
PHASE1 · PHASE2 · 21 planned enrolment
- Countries listed
- 1
- Registry update
- March 19, 2025
immortal.lifeTrial registrations containing the exact intervention label AL-001.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Only exact preferred-label or exact synonym matches are shown. Similar names are not treated as the same substance.
PHASE1 · PHASE2 · 21 planned enrolment
PHASE2 · 40 planned enrolment